https://www.selleckchem.com/pr....oducts/crenolanib-cp
793-3.704, P less then 0.001 and HR 1.599, 95% CI 1.185-2.159, P = 0.001, respectively). The International Cancer Genome Consortium (ICGC) database was used to externally validate the model, and the OS of low-risk patients were found to be longer than that of high-risk patients (P less then 0.001). The Nomograms of OS and DFS were plotted to help in clinical decision making. These results showed that the model was effective and may help in prognostic stratification of HCC patients. The prognostic prediction model based on R